https://news.medxy.ai/zh/medicaid-liver-transplant/Medxy AIzh2026-10-02T07:36:25-07:00Medicaid 扩大覆盖如何改善成人肝移植结局：长达十年的研究分析 https://news.medxy.ai/ja/medicaid-liver-transplant-2/Medxy AIja2026-10-02T07:36:08-07:00Medicaid拡大が成人肝移植転帰に与える影響：10年間の解析 https://news.medxy.ai/vi/medicaid-expansion-liver-transplant/Medxy AIvi2026-10-02T07:35:49-07:00Mở rộng Medicaid tác động thế nào đến kết cục ghép gan ở người lớn? Phân tích kéo dài 10 năm https://news.medxy.ai/impact-of-medicaid-expansion-on-adult-liver-transplant-outcomes-a-decade-long-analysis/Medxy AIen2026-10-02T07:35:29-07:00Impact of Medicaid Expansion on Adult Liver Transplant Outcomes: A Decade-Long Analysis https://news.medxy.ai/zh/lung-function-transplant/Medxy AIzh2026-10-02T07:34:43-07:00肝移植受者肺功能受损与呼吸困难：全国匹配队列研究带来的启示 https://news.medxy.ai/ja/lung-function-decline/Medxy AIja2026-10-02T07:34:23-07:00肝移植レシピエントにおける肺機能低下と呼吸困難：全国マッチドコホート研究からの示唆 https://news.medxy.ai/vi/lung-function-decline-2/Medxy AIvi2026-10-02T07:34:03-07:00Suy giảm chức năng phổi và khó thở ở người nhận ghép gan: bằng chứng từ một nghiên cứu đoàn hệ ghép cặp toàn quốc https://news.medxy.ai/impaired-pulmonary-function-and-dyspnea-in-liver-transplant-recipients-insights-from-a-nationwide-matched-cohort-study/Medxy AIen2026-10-02T07:33:43-07:00Impaired Pulmonary Function and Dyspnea in Liver Transplant Recipients: Insights from a Nationwide Matched Cohort Study https://news.medxy.ai/zh/liver-transplantation-advances/Medxy AIzh2026-10-02T07:32:59-07:00循环死亡后捐献肝移植新进展：常温机器灌注与区域灌注结局比较 https://news.medxy.ai/ja/liver-transplantation-comparison/Medxy AIja2026-10-02T07:32:35-07:00循環停止後臓器提供肝移植を前進させる：常温機械灌流と区域灌流の成績比較 https://news.medxy.ai/vi/liver-transplantation-comparison-2/Medxy AIvi2026-10-02T07:32:11-07:00Nâng tầm ghép gan từ người hiến sau ngừng tuần hoàn: so sánh kết cục tưới máu máy ở thân nhiệt bình thường và tưới máu vùng https://news.medxy.ai/advancing-donation-after-circulatory-death-liver-transplants-comparing-normothermic-machine-and-regional-perfusion-outcomes/Medxy AIen2026-10-02T07:31:48-07:00Advancing Donation After Circulatory Death Liver Transplants: Comparing Normothermic Machine and Regional Perfusion Outcomes https://news.medxy.ai/zh/dupilumab-eczema-kids/Medxy AIzh2026-10-02T07:31:04-07:00dupilumab治疗儿童中重度特应性皮炎：荷兰3年队列研究揭示长期疗效与安全性 https://news.medxy.ai/ja/dupilumab-child-eczema/Medxy AIja2026-10-02T07:30:42-07:00中等症から重症の小児アトピー性皮膚炎におけるDupilumabの長期有効性と安全性：オランダ3年間コホート研究からの知見 https://news.medxy.ai/vi/dupilumab-long-term-safety/Medxy AIvi2026-10-02T07:30:15-07:00Dupilumab duy trì hiệu quả và độ an toàn lâu dài ở trẻ em mắc viêm da cơ địa mức độ trung bình đến nặng: Kết quả từ nghiên cứu đoàn hệ 3 năm tại Hà Lan https://news.medxy.ai/sustained-efficacy-and-safety-of-dupilumab-in-children-with-moderate-to-severe-atopic-dermatitis-insights-from-a-3-year-dutch-cohort-study/Medxy AIen2026-10-02T07:29:55-07:00Sustained Efficacy and Safety of Dupilumab in Children with Moderate to Severe Atopic Dermatitis: Insights from a 3-Year Dutch Cohort Study https://news.medxy.ai/zh/arotitinib-cream-study/Medxy AIzh2026-10-02T07:29:01-07:001.5%芦可替尼乳膏治疗皮肤型扁平苔藓的疗效与安全性：随机临床试验综述 https://news.medxy.ai/ja/lansopitinib-skin-trial/Medxy AIja2026-10-02T07:28:41-07:00皮膚扁平苔癬に対するランソリチニブ外用クリームの有効性と安全性：ランダム化臨床試験レビュー https://news.medxy.ai/vi/ruxolitinib-cream-lichen-planus/Medxy AIvi2026-10-02T07:28:18-07:00Ruxolitinib cream trong lichen phẳng da: Hiệu quả, độ an toàn và ý nghĩa từ một thử nghiệm lâm sàng ngẫu nhiên https://news.medxy.ai/efficacy-and-safety-of-ruxolitinib-cream-in-patients-with-cutaneous-lichen-planus-a-randomized-clinical-trial-review/Medxy AIen2026-10-02T07:27:57-07:00Efficacy and Safety of Ruxolitinib Cream in Patients With Cutaneous Lichen Planus: A Randomized Clinical Trial Review https://news.medxy.ai/high-dose-oral-vitamin-d-for-management-of-chemotherapy-and-radiation-induced-skin-toxicity-a-multicenter-case-series/Medxy AIen2026-10-02T07:27:10-07:00High-Dose Oral Vitamin D for Management of Chemotherapy- and Radiation-Induced Skin Toxicity: A Multicenter Case Series https://news.medxy.ai/zh/rituximab-pemphigus-prediction/Medxy AIzh2026-10-02T07:26:27-07:00利妥昔单抗联合糖皮质激素治疗天疱疮患者短期结局的预测：来自中国多中心队列的启示 https://news.medxy.ai/ja/pemphigus-treatment-prediction/Medxy AIja2026-10-02T07:26:06-07:00リツキシマブ＋グルココルチコイド治療中の天疱瘡患者における短期転帰予測：中国多施設コホートからの知見 https://news.medxy.ai/vi/79791-2/Medxy AIvi2026-10-02T07:25:44-07:00Kết quả ngắn hạn của việc phối hợp rituximab và glucocorticoid ở bệnh nhân mắc bệnh pemphigus https://news.medxy.ai/predicting-short-term-outcomes-in-pemphigus-patients-treated-with-rituximab-and-glucocorticoids-insights-from-a-multicenter-chinese-cohort/Medxy AIen2026-10-02T07:25:26-07:00Predicting Short-Term Outcomes in Pemphigus Patients Treated with Rituximab and Glucocorticoids: Insights from a Multicenter Chinese Cohort https://news.medxy.ai/zh/dupilumab-atopic-dermatitis/Medxy AIzh2026-10-02T07:24:45-07:00儿童中重度特应性皮炎系统治疗新证据：PEDISTAD 登记研究显示 dupilumab 跨肤色疗效更佳 https://news.medxy.ai/ja/atopic-dermatitis-treatment/Medxy AIja2026-10-02T07:24:24-07:00PEDISTADレジストリが示した小児中等症から重症アトピー性皮膚炎に対する全身治療：皮膚色別の比較成績 https://news.medxy.ai/vi/atopic-dermatitis-treatment-2/Medxy AIvi2026-10-02T07:24:01-07:00Điều trị toàn thân viêm da cơ địa mức độ vừa đến nặng ở trẻ em: so sánh kết quả theo màu da từ cơ sở đăng ký PEDISTAD https://news.medxy.ai/systemic-therapies-for-pediatric-moderate-to-severe-atopic-dermatitis-comparative-outcomes-across-skin-colors-from-the-pedistad-registry/Medxy AIen2026-10-02T07:23:40-07:00Systemic Therapies for Pediatric Moderate-to-Severe Atopic Dermatitis: Comparative Outcomes Across Skin Colors from the PEDISTAD Registry https://news.medxy.ai/zh/plaque-psoriasis-flare/Medxy AIzh2026-10-02T07:22:58-07:00停用生物制剂后斑块型银屑病出现独特脓疱性发作：临床特征与危险因素 https://news.medxy.ai/ja/psoriasis-flare-after-treatment/Medxy AIja2026-10-02T07:22:38-07:00生物学的製剤中止後にみられる尋常性乾癬の特異的膿疱性増悪：臨床像と危険因子 https://news.medxy.ai/vi/psoriasis-pustular-flare/Medxy AIvi2026-10-02T07:22:16-07:00Bùng phát vảy nến mụn mủ đặc thù sau khi ngừng thuốc sinh học ở vảy nến mảng bám: đặc điểm lâm sàng và yếu tố nguy cơ https://news.medxy.ai/distinct-pustular-psoriasis-flares-after-biologic-withdrawal-in-plaque-psoriasis-clinical-features-and-risk-factors/Medxy AIen2026-10-02T07:21:53-07:00Distinct Pustular Psoriasis Flares After Biologic Withdrawal in Plaque Psoriasis: Clinical Features and Risk Factors https://news.medxy.ai/zh/breast-reconstruction-outcomes-2/Medxy AIzh2026-10-02T07:21:11-07:00两期乳房重建中聚二氧环己酮合成网片的短期结局：单中心比较研究的启示 https://news.medxy.ai/ja/polydioxanone-mesh-results/Medxy AIja2026-10-02T07:20:52-07:002期的乳房再建におけるポリジオキサノン合成メッシュの短期成績：単施設比較研究からの知見 https://news.medxy.ai/vi/polydioxanone-breast-reconstruction/Medxy AIvi2026-10-02T07:20:30-07:00Kết quả ngắn hạn của lưới tổng hợp polydioxanone trong tái tạo vú hai giai đoạn: Bằng chứng từ một nghiên cứu so sánh đơn trung tâm https://news.medxy.ai/short-term-outcomes-of-polydioxanone-synthetic-mesh-in-two-stage-breast-reconstruction-insights-from-a-single-center-comparative-study/Medxy AIen2026-10-02T07:20:12-07:00Short-Term Outcomes of Polydioxanone Synthetic Mesh in Two-Stage Breast Reconstruction: Insights from a Single-Center Comparative Study https://news.medxy.ai/zh/five-factor-weakness-index/Medxy AIzh2026-10-02T07:19:34-07:00五因素改良衰弱指数能否预测乳房缩小成形术后伤口愈合并发症？高龄或许更关键 https://news.medxy.ai/ja/breast-reduction-healing/Medxy AIja2026-10-02T07:19:11-07:00乳房縮小術後の創傷治癒合併症は予測できるか――5因子修正版フレイル指標の実力を検証 https://news.medxy.ai/vi/79748-2/Medxy AIvi2026-10-02T07:18:47-07:00Liệu có thể dự đoán các biến chứng lành vết thương sau phẫu thuật thu nhỏ vú? https://news.medxy.ai/assessing-the-predictive-value-of-the-5-factor-modified-frailty-index-for-wound-healing-complications-in-reduction-mammoplasty/Medxy AIen2026-10-02T07:18:25-07:00Assessing the Predictive Value of the 5-Factor Modified Frailty Index for Wound-Healing Complications in Reduction Mammoplasty https://news.medxy.ai/zh/adm-reconstruction-timing/Medxy AIzh2026-10-02T07:17:44-07:00前胸壁两期乳房重建中ADM植入时机如何优化：在包膜挛缩与并发症之间寻找平衡 https://news.medxy.ai/ja/adm-timing-optimization/Medxy AIja2026-10-02T07:17:25-07:00前胸壁2段階乳房再建におけるADM留置時期の最適化：被膜拘縮と合併症の両立 https://news.medxy.ai/vi/optimal-adm-timing/Medxy AIvi2026-10-02T07:17:05-07:00Tối ưu thời điểm đặt Acellular Dermal Matrix trong tái tạo vú trước cơ hai thì: Cân bằng giữa co thắt bao xơ và biến chứng https://news.medxy.ai/optimizing-acellular-dermal-matrix-timing-in-2-stage-prepectoral-breast-reconstruction-balancing-capsular-contracture-and-complications/Medxy AIen2026-10-02T07:16:43-07:00Optimizing Acellular Dermal Matrix Timing in 2-Stage Prepectoral Breast Reconstruction: Balancing Capsular Contracture and Complications https://news.medxy.ai/zh/optimize-dermal-matrix-size/Medxy AIzh2026-10-02T07:16:03-07:00优化无细胞真皮基质尺寸：降低胸肌前乳房重建包膜挛缩风险 https://news.medxy.ai/ja/adm-size-optimization/Medxy AIja2026-10-02T07:15:42-07:00前胸筋下乳房再建における被膜拘縮を抑えるADMサイズの最適化 https://news.medxy.ai/vi/optimize-dermal-matrix/Medxy AIvi2026-10-02T07:15:18-07:00Tối ưu hóa kích thước acellular dermal matrix để giảm co thắt bao xơ trong tái tạo vú trước cơ ngực https://news.medxy.ai/optimizing-acellular-dermal-matrix-size-to-minimize-capsular-contracture-in-prepectoral-breast-reconstruction/Medxy AIen2026-10-02T07:14:57-07:00Optimizing Acellular Dermal Matrix Size to Minimize Capsular Contracture in Prepectoral Breast Reconstruction https://news.medxy.ai/zh/migraine-surgery-timing/Medxy AIzh2026-10-02T07:14:17-07:00偏头痛触发点手术越早做，术后头痛改善越明显：来自台湾队列研究的启示 https://news.medxy.ai/ja/migraine-surgery-timing-2/Medxy AIja2026-10-02T07:13:55-07:00片頭痛手術は早いほど良い？ 台湾コホート研究が示す術後頭痛改善の鍵 https://news.medxy.ai/vi/79731-2/Medxy AIvi2026-10-02T07:13:34-07:00Phẫu thuật điều trị đau nửa đầu: Càng sớm càng tốt? Nghiên cứu đoàn hệ tại Đài Loan chỉ ra chìa khóa giúp cải thiện tình trạng đau đầu sau phẫu thuật https://news.medxy.ai/earlier-intervention-with-migraine-trigger-site-surgery-linked-to-improved-postoperative-headache-outcomes-insights-from-a-taiwanese-cohort-study/Medxy AIen2026-10-02T07:13:14-07:00Earlier Intervention with Migraine Trigger-Site Surgery Linked to Improved Postoperative Headache Outcomes: Insights from a Taiwanese Cohort Study https://news.medxy.ai/zh/awake-microsurgery/Medxy AIzh2026-10-01T07:12:33-07:00体弱患者头颈部游离皮瓣重建的新选择：清醒整合式显微外科方法兼顾安全与资源效率 https://news.medxy.ai/ja/awake-microsurgery-2/Medxy AIja2026-10-01T07:12:14-07:00フレイル患者の頭頸部遊離皮弁再建に対するAwake Integrated Microsurgical法：全身麻酔に代わる安全で資源効率の高い選択肢 https://news.medxy.ai/vi/79726-2/Medxy AIvi2026-10-01T07:11:48-07:00Một lựa chọn mới cho phẫu thuật tái tạo vùng đầu mặt cổ bằng vạt tự do ở bệnh nhân thể trạng yếu https://news.medxy.ai/awake-integrated-microsurgical-approach-for-head-and-neck-free-flap-reconstruction-in-frail-patients-a-safe-and-resource-efficient-alternative-to-general-anesthesia/Medxy AIen2026-10-01T07:11:27-07:00Awake Integrated Microsurgical Approach for Head and Neck Free Flap Reconstruction in Frail Patients: A Safe and Resource-Efficient Alternative to General Anesthesia https://news.medxy.ai/zh/early-tracheostomy-tbi/Medxy AIzh2026-10-01T07:10:42-07:00重型TBI中早期气管切开与撤除维持生命治疗：一项全国性研究揭示医院差异 https://news.medxy.ai/ja/79722-2/Medxy AIja2026-10-01T07:10:22-07:00重症外傷性脳損傷（TBI）における早期気管切開と生命維持治療の中止 https://news.medxy.ai/vi/early-tracheostomy-tracheostomy-variation/Medxy AIvi2026-10-01T07:09:58-07:00Sự khác biệt giữa các bệnh viện về mở khí quản sớm và ngừng điều trị duy trì sự sống trong chấn thương sọ não nặng: Góc nhìn từ một nghiên cứu toàn quốc https://news.medxy.ai/hospital-variation-in-early-tracheostomy-and-life-sustaining-treatment-withdrawal-in-severe-tbi-insights-from-a-nationwide-study/Medxy AIen2026-10-01T07:09:36-07:00Hospital Variation in Early Tracheostomy and Life-Sustaining Treatment Withdrawal in Severe TBI: Insights from a Nationwide Study https://news.medxy.ai/zh/icu-brain-death-survey/Medxy AIzh2026-10-01T07:08:47-07:00瑞士多中心调查：ICU医护人员如何看待脑死亡 https://news.medxy.ai/ja/icu-staff-brain-death/Medxy AIja2026-10-01T07:08:27-07:00スイス多施設調査でみるICUスタッフの脳死観：認識と知識の実態 https://news.medxy.ai/vi/icu-staff-brain-death-2/Medxy AIvi2026-10-01T07:08:00-07:00Khảo sát đa trung tâm tại Thụy Sĩ: Nhân viên ICU nhìn nhận thế nào về chết não? https://news.medxy.ai/exploring-icu-staff-perspectives-on-brain-death-insights-from-a-swiss-multicenter-survey/Medxy AIen2026-10-01T07:07:39-07:00Exploring ICU Staff Perspectives on Brain Death: Insights from a Swiss Multicenter Survey https://news.medxy.ai/zh/sepsis-temperature-subtypes/Medxy AIzh2026-10-01T07:06:57-07:00脓毒症体温轨迹亚表型的国际验证：揭示免疫与凝血特征及免疫球蛋白治疗意义 https://news.medxy.ai/ja/79712-2/Medxy AIja2026-10-01T07:06:38-07:00敗血症における体温推移のサブフェノタイプに関する国際的検証：免疫・凝固特性および免疫グロブリン療法の意義の解明 https://news.medxy.ai/vi/sepsis-biomarkers/Medxy AIvi2026-10-01T07:06:16-07:00Xác thực quốc tế các dưới kiểu hình sepsis theo quỹ đạo nhiệt độ hé lộ đặc điểm miễn dịch và đông máu, gợi ý ý nghĩa cho liệu pháp immunoglobulin https://news.medxy.ai/international-validation-of-sepsis-temperature-trajectory-subphenotypes-reveals-immune-and-coagulation-profiles-with-implications-for-immunoglobulin-therapy/Medxy AIen2026-10-01T07:05:54-07:00International Validation of Sepsis Temperature-Trajectory Subphenotypes Reveals Immune and Coagulation Profiles with Implications for Immunoglobulin Therapy https://news.medxy.ai/zh/optimize-language-model/Medxy AIzh2026-10-01T07:05:13-07:00优化大语言模型以提升住院出院预测：一项回顾性队列研究 https://news.medxy.ai/ja/hospital-discharge-prediction/Medxy AIja2026-10-01T07:04:53-07:00病院退院予測を高精度化する大規模言語モデル：最適化プロンプトを用いた後ろ向きコホート研究 https://news.medxy.ai/vi/optimize-language-model-2/Medxy AIvi2026-10-01T07:04:33-07:00Tối ưu hóa mô hình ngôn ngữ lớn để dự đoán xuất viện: một nghiên cứu đoàn hệ hồi cứu https://news.medxy.ai/enhancing-hospital-discharge-prediction-with-optimized-large-language-models-a-retrospective-cohort-study/Medxy AIen2026-10-01T07:04:15-07:00Enhancing Hospital Discharge Prediction with Optimized Large Language Models: A Retrospective Cohort Study https://news.medxy.ai/zh/trauma-informed-care/Medxy AIzh2026-10-01T07:03:34-07:00贯通知识与实践：不同医学培训阶段的创伤知情照护 https://news.medxy.ai/ja/trauma-informed-care-2/Medxy AIja2026-10-01T07:03:15-07:00医学教育の各段階をつなぐトラウマ・インフォームド・ケア：知識と実践の架け橋 https://news.medxy.ai/vi/bridging-knowledge-practice/Medxy AIvi2026-10-01T07:02:55-07:00Thu hẹp khoảng cách giữa kiến thức và thực hành: Chăm sóc lấy sang chấn trong các giai đoạn đào tạo y khoa https://news.medxy.ai/bridging-knowledge-and-practice-trauma-informed-care-across-medical-training-stages/Medxy AIen2026-10-01T07:02:35-07:00Bridging Knowledge and Practice: Trauma-Informed Care Across Medical Training Stages https://news.medxy.ai/zh/car-t-cell-therapy-lymphoma/Medxy AIzh2026-10-01T07:01:55-07:00CAR T 细胞治疗重塑复发/难治性原发纵隔 B 细胞淋巴瘤结局：REPRIME-FIL 与 CART-SIE 合并分析启示 https://news.medxy.ai/ja/car-t-cell-therapy-prognosis-2/Medxy AIja2026-10-01T07:01:21-07:00再発・難治性原発性縦隔B細胞リンパ腫の予後を変えるCAR T細胞療法：REPRIME-FIL・CART-SIE統合解析からの示唆 https://news.medxy.ai/vi/car-t-therapy-lymphoma-2/Medxy AIvi2026-10-01T07:00:57-07:00Liệu pháp tế bào CAR T cải thiện rõ rệt tiên lượng u lympho tế bào B trung thất nguyên phát tái phát/kháng trị: phân tích gộp REPRIME-FIL và CART-SIE https://news.medxy.ai/car-t-cell-therapy-revolutionizes-outcomes-in-relapsed-refractory-primary-mediastinal-b-cell-lymphoma-insights-from-pooled-reprime-fil-and-cart-sie-analyses/Medxy AIen2026-10-01T07:00:33-07:00CAR T-Cell Therapy Revolutionizes Outcomes in Relapsed/Refractory Primary Mediastinal B-Cell Lymphoma: Insights from Pooled REPRIME-FIL and CART-SIE Analyses https://news.medxy.ai/zh/bcma-car-t-rescue/Medxy AIzh2026-10-01T06:57:34-07:00GPRC5D CAR T 失败后，多发性骨髓瘤的 BCMA 靶向 CAR T 挽救治疗：疗效与安全性 https://news.medxy.ai/ja/bcma-car-t-myeloma/Medxy AIja2026-10-01T06:57:14-07:00GPRC5D CAR T失敗後多発性骨髄腫に対するBCMA標的CAR T療法：救済治療としての有効性と安全性 https://news.medxy.ai/vi/car-t-therapy-multiple-myeloma-2/Medxy AIvi2026-10-01T06:56:54-07:00Hiệu quả và độ an toàn của liệu pháp CAR T nhắm BCMA như điều trị cứu vãn ở đa u tủy xương sau thất bại với CAR T nhắm GPRC5D https://news.medxy.ai/efficacy-and-safety-of-bcma-targeted-car-t-therapy-as-salvage-treatment-in-multiple-myeloma-post-gprc5d-car-t-cell-failure/Medxy AIen2026-10-01T06:56:33-07:00Efficacy and Safety of BCMA-Targeted CAR T Therapy as Salvage Treatment in Multiple Myeloma Post-GPRC5D CAR T-Cell Failure https://news.medxy.ai/zh/79683-2/Medxy AIzh2026-10-01T06:55:55-07:00维奈克拉（Venetoclax）与奥加霉素伊诺妥珠单抗（Inotuzumab Ozogamicin）的协同治疗在复发/难治性B细胞急性淋巴细胞白血病中显示出良好的疗效 https://news.medxy.ai/ja/benetoclax-inotuzumab-therapy/Medxy AIja2026-10-01T06:55:36-07:00再発・難治性B細胞急性リンパ性白血病に対するベネトクラクス＋イノツズマブ オゾガマイシン併用療法、有望な成績を示す https://news.medxy.ai/synergistic-therapy-with-venetoclax-and-inotuzumab-ozogamicin-shows-promising-outcomes-in-relapsed-refractory-b-cell-acute-lymphoblastic-leukemia/Medxy AIen2026-10-01T06:54:51-07:00Synergistic Therapy with Venetoclax and Inotuzumab Ozogamicin Shows Promising Outcomes in Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia https://news.medxy.ai/zh/blood-tumor-expertise/Medxy AIzh2026-10-01T06:54:11-07:00你其实早已具备应对能力：发挥血液肿瘤学专长参与放射大规模伤亡救治 https://news.medxy.ai/ja/radiation-multitrauma-care/Medxy AIja2026-10-01T06:53:47-07:00もう訓練済みの領域へ――放射線多数傷病者対応に活かす血液腫瘍内科の専門性 https://news.medxy.ai/vi/hematology-oncology-radiation-response/Medxy AIvi2026-10-01T06:53:23-07:00Khi đã có sẵn năng lực: Phát huy chuyên môn huyết học – ung bướu trong xử trí thương vong hàng loạt do bức xạ https://news.medxy.ai/you-are-already-trained-for-this-harnessing-hematology-oncology-expertise-in-radiation-mass-casualty-management/Medxy AIen2026-10-01T06:52:58-07:00You Are Already Trained for This: Harnessing Hematology-Oncology Expertise in Radiation Mass Casualty Management https://news.medxy.ai/zh/venetoclax-pediatric-chemotherapy/Medxy AIzh2026-10-01T06:52:16-07:00Venetoclax 联合儿科启发式化疗：为 Ph 阴性急性淋巴细胞白血病青少年与成人带来更佳结局 https://news.medxy.ai/ja/79672-2/Medxy AIja2026-10-01T06:51:57-07:00ベネトクラクスと小児型化学療法の併用：Ph陰性急性リンパ芽球性白血病の若年者および成人における転帰の改善 https://news.medxy.ai/vi/venetoclax-chemotherapy-all/Medxy AIvi2026-10-01T06:51:34-07:00Venetoclax phối hợp hóa trị theo hướng nhi khoa giúp cải thiện kết cục ở thanh thiếu niên và người lớn mắc ALL Ph- https://news.medxy.ai/venetoclax-combined-with-pediatric-inspired-chemotherapy-enhances-outcomes-in-adolescents-and-adults-with-ph-negative-acute-lymphoblastic-leukemia/Medxy AIen2026-10-01T06:51:12-07:00Venetoclax Combined with Pediatric-Inspired Chemotherapy Enhances Outcomes in Adolescents and Adults with Ph-Negative Acute Lymphoblastic Leukemia https://news.medxy.ai/zh/endogenous-endophthalmitis-features/Medxy AIzh2026-10-01T06:50:30-07:00不同病原体所致培养阳性内源性眼内炎的临床特征与结局：一项12年多中心研究 https://news.medxy.ai/ja/endogenous-endophthalmitis-study/Medxy AIja2026-10-01T06:50:07-07:00病原体別にみた培養陽性内因性眼内炎の臨床像と転帰：12年間の多施設研究からの知見 https://news.medxy.ai/vi/endogenous-endophthalmitis/Medxy AIvi2026-10-01T06:49:39-07:00Viêm nội nhãn nội sinh có cấy dương tính: đặc điểm lâm sàng và tiên lượng khác nhau theo từng tác nhân qua nghiên cứu đa trung tâm 12 năm https://news.medxy.ai/distinct-clinical-profiles-and-outcomes-of-culture-positive-endogenous-endophthalmitis-by-pathogen-insights-from-a-12-year-multicenter-study/Medxy AIen2026-10-01T06:49:14-07:00Distinct Clinical Profiles and Outcomes of Culture-Positive Endogenous Endophthalmitis by Pathogen: Insights from a 12-Year Multicenter Study https://news.medxy.ai/zh/early-atrophic-amd/Medxy AIzh2026-10-01T06:48:34-07:00解析早期萎缩型年龄相关性黄斑变性的结构—功能联系：靶向评估与管理的临床意义 https://news.medxy.ai/ja/79662-2/Medxy AIja2026-10-01T06:48:12-07:00早期萎縮型加齢黄斑変性における構造と機能の関連の解析 https://news.medxy.ai/vi/79661-2/Medxy AIvi2026-10-01T06:47:49-07:00Phân tích mối quan hệ giữa cấu trúc và chức năng trong thoái hóa điểm vàng do tuổi tác thể teo giai đoạn sớm https://news.medxy.ai/decoding-structure-function-links-in-early-atrophic-age-related-macular-degeneration-implications-for-targeted-assessment-and-management/Medxy AIen2026-10-01T06:47:24-07:00Decoding Structure-Function Links in Early Atrophic Age-Related Macular Degeneration: Implications for Targeted Assessment and Management https://news.medxy.ai/zh/orbital-epithelioid-hemangioma/Medxy AIzh2026-10-01T06:46:45-07:00眶内及眶周上皮样血管瘤：来自 25 例多中心研究的临床与影像学启示 https://news.medxy.ai/ja/orbital-vascular-tumor-study/Medxy AIja2026-10-01T06:46:24-07:00眼窩・眼窩周囲類上皮性血管腫25例の多施設研究：臨床像と画像所見から見えた特徴 https://news.medxy.ai/orbital-and-periorbital-epithelioid-hemangioma-clinical-and-radiological-insights-from-a-multicentre-study-of-25-cases/Medxy AIen2026-10-01T06:45:47-07:00Orbital and Periorbital Epithelioid Hemangioma: Clinical and Radiological Insights from a Multicentre Study of 25 Cases https://news.medxy.ai/zh/hearing-loss-amyloid/Medxy AIzh2026-10-01T06:45:06-07:00听力下降与脑区淀粉样蛋白沉积：来自在体PET影像与神经病理学研究的启示 https://news.medxy.ai/ja/hearing-loss-amyloid-2/Medxy AIja2026-10-01T06:44:40-07:00聴力低下と脳領域別アミロイド沈着：生体内PET画像と神経病理学的関連からの示唆 https://news.medxy.ai/vi/hearing-loss-amyloid-brain/Medxy AIvi2026-10-01T06:44:09-07:00Mất thính lực và lắng đọng amyloid ở não theo vùng: Góc nhìn từ PET in vivo và các tương quan bệnh lý thần kinh https://news.medxy.ai/hearing-loss-and-regional-brain-amyloid-deposition-insights-from-in-vivo-pet-imaging-and-neuropathological-correlates/Medxy AIen2026-10-01T06:43:43-07:00Hearing Loss and Regional Brain Amyloid Deposition: Insights from In Vivo PET Imaging and Neuropathological Correlates https://news.medxy.ai/zh/nasal-septum-repair/Medxy AIzh2026-10-01T06:42:52-07:00鼻中隔穿孔修复如何更优：个体化术式与风险因素管理 https://news.medxy.ai/ja/79647-2/Medxy AIja2026-10-01T06:42:32-07:00鼻中隔穿孔修復をより良好に行うために：個別化された術式とリスク因子の管理 https://news.medxy.ai/vi/79646-2/Medxy AIvi2026-10-01T06:42:11-07:00Tối ưu hóa quy trình vá lỗ thủng vách ngăn mũi: Các phương pháp phẫu thuật cá thể hóa và quản lý yếu tố nguy cơ https://news.medxy.ai/optimizing-surgical-repair-of-nasal-septal-perforations-tailored-techniques-and-risk-factor-management/Medxy AIen2026-10-01T06:41:48-07:00Optimizing Surgical Repair of Nasal Septal Perforations: Tailored Techniques and Risk Factor Management https://news.medxy.ai/zh/intraoperative-nerve-monitoring/Medxy AIzh2026-10-01T06:41:02-07:00术中喉返神经监测对甲状腺切除术后气道结局的影响：来自大型国家队列的研究见解 https://news.medxy.ai/ja/recurrent-nerve-monitoring/Medxy AIja2026-10-01T06:40:41-07:00甲状腺手術後の気道転帰を左右する術中反回神経モニタリング：大規模全国コホートからの知見 https://news.medxy.ai/vi/recurrent-laryngeal-nerve-monitoring/Medxy AIvi2026-10-01T06:40:17-07:00Theo dõi dây thần kinh thanh quản quặt ngược trong mổ có cải thiện kết cục đường thở sau cắt tuyến giáp không? Góc nhìn từ một đoàn hệ quốc gia quy mô lớn https://news.medxy.ai/impact-of-intraoperative-recurrent-laryngeal-nerve-monitoring-on-post-thyroidectomy-airway-outcomes-insights-from-a-large-national-cohort/Medxy AIen2026-10-01T06:39:56-07:00Impact of Intraoperative Recurrent Laryngeal Nerve Monitoring on Post-Thyroidectomy Airway Outcomes: Insights from a Large National Cohort https://news.medxy.ai/zh/ventriculoperitoneal-shunt-management/Medxy AIzh2026-10-01T06:39:11-07:00急诊腹部手术中脑室-腹腔分流管如何管理：25年回顾性队列研究带来的证据 https://news.medxy.ai/ja/ventriculoperitoneal-shunt-management-2/Medxy AIja2026-10-01T06:38:49-07:00緊急腹部手術における脳室腹腔シャント管理の最適化：25年間後ろ向きコホート研究からのエビデンス https://news.medxy.ai/vi/ventriculoperitoneal-shunt-optimization/Medxy AIvi2026-10-01T06:38:26-07:00Tối ưu hóa xử trí dẫn lưu não thất–phúc mạc trong phẫu thuật bụng cấp cứu: Bằng chứng từ một đoàn hệ hồi cứu 25 năm https://news.medxy.ai/optimizing-ventriculoperitoneal-shunt-management-during-emergency-abdominal-surgery-evidence-from-a-25-year-retrospective-cohort/Medxy AIen2026-10-01T06:38:07-07:00Optimizing Ventriculoperitoneal Shunt Management During Emergency Abdominal Surgery: Evidence from a 25-Year Retrospective Cohort https://news.medxy.ai/zh/vte-chemoprophylaxis-review/Medxy AIzh2026-10-01T06:37:19-07:00胰腺切除术后延长VTE化学预防是否需要重新审视：当前皮下注射方案真的有效吗？ https://news.medxy.ai/ja/reconsider-vte-prophylaxis/Medxy AIja2026-10-01T06:37:00-07:00膵切除後の延長VTE化学予防を再考する：現行の皮下投与は有効か？ https://news.medxy.ai/vi/vte-prophylaxis-review/Medxy AIvi2026-10-01T06:36:36-07:00Có nên xem xét lại dự phòng VTE kéo dài sau cắt tụy do ung thư? Liệu đường tiêm dưới da hiện nay có đủ hiệu quả? https://news.medxy.ai/rethinking-extended-vte-chemoprophylaxis-after-pancreatectomy-for-cancer-is-the-current-subcutaneous-approach-effective/Medxy AIen2026-10-01T06:36:15-07:00Rethinking Extended VTE Chemoprophylaxis After Pancreatectomy for Cancer: Is the Current Subcutaneous Approach Effective? https://news.medxy.ai/zh/lobular-carcinoma-staging/Medxy AIzh2026-10-01T06:35:33-07:00cT1N0 浸润性小叶癌的腋窝分期升级：基于 SOUND 试验证据评估前哨淋巴结活检省略的适用性 https://news.medxy.ai/ja/79627-2/Medxy AIja2026-10-01T06:35:13-07:00cT1N0浸潤性小葉癌における腋窩病期の上方修正：センチネルリンパ節生検省略の妥当性の評価 https://news.medxy.ai/vi/axillary-node-metastasis-breast-cancer/Medxy AIvi2026-10-01T06:34:51-07:00Di căn hạch nách trong ung thư biểu mô tiểu thùy xâm nhập cT1N0: Có thể bỏ qua sinh thiết hạch lính gác theo bằng chứng từ thử nghiệm SOUND hay không? https://news.medxy.ai/axillary-nodal-upstaging-in-ct1n0-invasive-lobular-carcinoma-assessing-sentinel-lymph-node-biopsy-omission-based-on-sound-trial-evidence/Medxy AIen2026-10-01T06:34:29-07:00Axillary Nodal Upstaging in cT1N0 Invasive Lobular Carcinoma: Assessing Sentinel Lymph Node Biopsy Omission Based on SOUND Trial Evidence https://news.medxy.ai/zh/testosterone-therapy-review/Medxy AIzh2026-10-01T06:23:08-07:00重新审视睾酮治疗：基于两项里程碑随机试验的疗效与安全性解读 https://news.medxy.ai/ja/testosterone-therapy/Medxy AIja2026-10-01T06:22:50-07:00Testosterone療法を再考する：2つの画期的無作為化試験が示す有効性と安全性の要点 https://news.medxy.ai/vi/testosterone-therapy-review-2/Medxy AIvi2026-10-01T06:22:26-07:00Đánh giá lại liệu pháp testosterone: Những phát hiện từ hai thử nghiệm ngẫu nhiên kinh điển về hiệu quả và tính an toàn https://news.medxy.ai/reassessing-testosterone-therapy-insights-from-two-landmark-randomized-trials-on-efficacy-and-safety/Medxy AIen2026-10-01T06:22:07-07:00Reassessing Testosterone Therapy: Insights from Two Landmark Randomized Trials on Efficacy and Safety https://news.medxy.ai/zh/treg-cells-gvhd-prevention/Medxy AIzh2026-10-01T06:14:08-07:00借助扩增的抗原特异性供者调节性T细胞预防异基因造血细胞移植后GVHD https://news.medxy.ai/ja/treg-gvhd-prevention/Medxy AIja2026-10-01T06:13:48-07:00同種造血細胞移植におけるGVHD予防を目指す、抗原特異的ドナー制御性T細胞の活用 https://news.medxy.ai/vi/regulatory-t-cells-gvhd-prevention/Medxy AIvi2026-10-01T06:13:25-07:00Tận dụng tế bào T điều hòa của người cho đặc hiệu kháng nguyên đã được mở rộng để phòng ngừa GVHD trong ghép tế bào tạo máu dị gen https://news.medxy.ai/harnessing-expanded-antigen-specific-donor-regulatory-t-cells-to-prevent-gvhd-in-allogeneic-hematopoietic-cell-transplantation/Medxy AIen2026-10-01T06:13:02-07:00Harnessing Expanded Antigen-Specific Donor Regulatory T Cells to Prevent GVHD in Allogeneic Hematopoietic Cell Transplantation